Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Emmessar Biotech & Nutrition Ltd has informed BSE that the trading window for its securities will remain closed from January 1, 2026, until 48 hours after the financial results for the quarter ending December 31, 2025 become publicly available. This is filed in compliance with SEBI's Prohibition of Insider Trading Regulations, 2015 (Schedule B, Clause 4). The signed communication is from Priyanka Sharma, Company Secretary. No specific earnings date is given yet, but the quiet period applies to all insiders including directors and employees.
Routine compliance filing with no direct impact on share price. It signals that Q3 FY26 results are upcoming, likely to be announced in January or early February 2026 — retail investors should watch for the earnings release after the window reopens.